Taub Rebecca sold MDGL
August 12, 2025 · Form 4 insider transaction
Taub Rebecca sold 3,580 shares of Madrigal Pharmaceuticals, Inc. at $350.87 per share, a transaction worth $1.26M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
3,580
Price
$350.87
Total value
$1.26M
InsiderTaub Rebecca
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 12, 2025
Filing dateAugust 13, 2025
Shares owned after500,727
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.10 to $351.08, inclusive.